EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hemodiafiltration versus High-Flux Hemodialysis and Risk of Mortality

Giovanni F M Strippoli, Giovanni Tripepi, Bernard Canaud iD, Stefano Stuard iD, Franklin W Maddux, Len A Usvyat iD, Paola Carioni iD, Matteo Savoia, Germaine Wong iD, Carmine Zoccali iD

Journal of the American Society of Nephrology · 13.08.2026

DOI: 10.1681/asn.0000001225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 13.08.2026. Verfasst von Giovanni F M Strippoli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Jonian Area (Dimepre-J), University of Bari, Bari, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Randomized trials suggested that hemodiafiltration improved survival over high-flux hemodialysis, but real-world evidence is limited. Target trial emulation showed that hemodiafiltration was associated with lower mortality than high-flux hemodialysis. The findings supported broader use of hemodiafiltration when technically feasible and clinically appropriate.

Background

Randomized trials suggest that high-volume postdilution hemodiafiltration (HDF) may improve survival compared with high-flux hemodialysis, but evidence from routine clinical practice and from regions underrepresented in trials remains limited.

Methods

We emulated a target trial comparing HDF with high-flux hemodialysis using data from European Clinical Database, a multinational registry of dialysis patients treated in 8 European countries. Adults receiving thrice-weekly in-center dialysis between 2014 and 2019 were eligible. Follow-up began 91 days after dialysis initiation. Sustained treatment strategies were defined as receipt of the assigned modality for at least 90% of sessions. Inverse probability weighting was used to emulate randomized treatment assignment. The primary outcome was all-cause mortality, with kidney transplantation treated as a competing event.

Results

Among 19,539 eligible patients at day 91, inverse probability weighting created a weighted pseudopopulation of 19,758 patients (8641 HDF; 11,117 hemodialysis). During a median follow-up of 16 months (interquartile range, 6–32), 4282 deaths occurred. HDF was associated with a lower risk of all-cause mortality compared with high-flux hemodialysis (hazard ratio, 0.72; 95% confidence interval, 0.67 to 0.77). At 2 years, the weighted cumulative incidence of death was 20.6% in the HDF group and 22.3% in the hemodialysis group, corresponding to an absolute risk reduction of 1.7% points. The results were consistent across sensitivity analyses, including analyses accounting for country, competing risks, informative censoring, protocol adherence, and an intention-to-treat–like exposure definition. The association was broadly similar across prespecified subgroups, with only a stronger relative benefit observed among patients with preexisting cardiovascular disease (interaction P < 0.001). Higher delivered convective volumes were associated with better survival; however, these findings should be interpreted cautiously because higher convective volumes may reflect patient stability and center expertise rather than a causal dose–response relationship.

Conclusions

In this large multinational target trial emulation, sustained high-volume postdilution HDF was associated with lower mortality than high-flux hemodialysis.

Schlagwörter

Stichwörter der Autor:innen

epidemiology and outcomeshemodialysis

Autor:innen und Institutionen

  • Department of Precision and Regenerative Medicine and Jonian Area (Dimepre-J), University of Bari, Bari, Italy.
  • School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
  • Institute of Clinical Physiology (CNR-IFC), Reggio Calabria, Italy.
  • School of Medicine, Montpellier University, Montpellier, France.
  • Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.
  • Fresenius Medical Care, Global Medical Office, Palazzo Pignano, Italy.

ORCID-Profile: Bernard Canaud, Stefano Stuard, Len A Usvyat, Paola Carioni, Germaine Wong, Carmine Zoccali

Zitieren

APA

Strippoli, G. F. M., Tripepi, G., Canaud, B., Stuard, S., Maddux, F. W., Usvyat, L. A., Carioni, P., Savoia, M., Wong, G., & Zoccali, C. (2026). Hemodiafiltration versus High-Flux Hemodialysis and Risk of Mortality. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001225

Vancouver

Strippoli GFM, Tripepi G, Canaud B, Stuard S, Maddux FW, Usvyat LA, et al. Hemodiafiltration versus High-Flux Hemodialysis and Risk of Mortality. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001225

BibTeX
@article{Strippoli2026,
  author = {Strippoli, Giovanni F M and Tripepi, Giovanni and Canaud, Bernard and Stuard, Stefano and Maddux, Franklin W and Usvyat, Len A and Carioni, Paola and Savoia, Matteo and Wong, Germaine and Zoccali, Carmine},
  title = {Hemodiafiltration versus High-Flux Hemodialysis and Risk of Mortality},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000001225}
}
Kostenlos starten →